HUM-MOLGEN archive: HUM-MOLGEN News Alert

__________________________________________________________________________ Quantitative PCR March 19-21, 2007 | San Diego, CA http://www.healthtech.com/2007/qpc/index.asp Its simplicity, specificity, and sensitivity, together with the potential for high-throughput and ongoing introduction of new chemistries, more reliable instrumentation, and improved protocols continue qPCR as the validation tool of choice. Learn from savvy, seasoned researchers as they share their experiences with the latest technologies and their cutting edge results at CHI's Quantitative PCR: Replicating and Validating Success. __________________________________________________________________________ INTERNATIONAL COMMUNICATION FORUM IN HUMAN MOLECULAR GENETICS HUM-MOLGEN News Alert - January 10, 2007 - http://hum-molgen.org DIAGnostics - Clinical Research (professional requests) http://hum-molgen.org/clinical-research/ - Meckel-Gruber syndrome or Joubert syndrome: call for patients http://hum-molgen.org/bb/Forum2/HTML/000202.html - Post diagnostic request / call for collaboration http://hum-molgen.org/diagnostic-posting or contact admin@hum-molgen.org Genetic News by T.M. D'Souza, S. Chandler, T. Dalaya, R. Kimmel, K. Markey, J. Mill, La Merie S.L, R. Nemade, F.S. Zollmann http://hum-molgen.org/NewsGen - Ectopic Expression Of Glucagon-Like Peptide 1 For Gene Therapy Of Type II Diabetes Study results demonstrate the feasibility of gene therapy for type II diabetes using GLP-1 expression vectors. http://hum-molgen.org/NewsGen/01-2007/000015.html - Gene Therapy In Wound Healing: Present Status And Future Directions Article aims to review the research on gene therapy in wound healing and possible future directions in this exciting field. http://hum-molgen.org/NewsGen/01-2007/000014.html - Development Of A Novel Systemic Gene Delivery System For Cancer Therapy With A Tumor-Specific Cleavable PEG-Lipid Multifunctional Envelope-type Nano Device (MEND) modified with PPD is a promising device, which has the potential to make in vivo cancer gene therapy achievable. http://hum-molgen.org/NewsGen/01-2007/000013.html - New Streptococcal Virulence Factors Degradation of host glycogen is an important factor in bacterial pathogenesis. http://hum-molgen.org/NewsGen/01-2007/000012.html - Tolerating The Gut New research reveals why the immune system remains in check and does not attack gut tissues despite being full of bacteria. http://hum-molgen.org/NewsGen/01-2007/000011.html - Genetic Risk Factor For Crohn Disease Found A variant of a protein that normally promotes the digestion and clearance of bacteria by cells is associated with elevated risk of Crohn disease. http://hum-molgen.org/NewsGen/01-2007/000009.html - New Breast Cancer Susceptibility Gene Identified Individuals with mutations in a gene called PALB2 have more than twice the normal risk of breast cancer. http://hum-molgen.org/NewsGen/01-2007/000008.html - New Genetic Cause Of An Immunodeficiency Syndrome Found A gene called HAX1 is mutated in some individuals with an immunodeficiency syndrome known as severe congenital neutropenia (SCN). http://hum-molgen.org/NewsGen/01-2007/000007.html - Activating Drug Discovery For Gaucher Disease Scientists have identified a new structural form of the protein that is mutated in Gaucher disease. http://hum-molgen.org/NewsGen/01-2007/000006.html - Beefing Up Resistance To Mad Cow Disease A team of American and Japanese scientists has created cows that lack the protein responsible for mad cow disease. http://hum-molgen.org/NewsGen/01-2007/000005.html - Neurons Group Abstract Movement Scientists describe neurons in the lateral prefrontal cortex that become active before certain categories of movement. http://hum-molgen.org/NewsGen/01-2007/000004.html - Progeria Mutation Sheds Light On Normal Ageing Researchers provide firm evidence that specifically DNA damage contributes to ageing. http://hum-molgen.org/NewsGen/01-2007/000003.html - Starve The Tumour, Sabotage The Blood Supply A new drug that shrinks tumours by sabotaging their blood supply may work against cancers that have become resistant to standard anti-angiogenic therapies. http://hum-molgen.org/NewsGen/01-2007/000002.html - Microbial Component To Obesity The microbes living in our guts may influence how prone we are to obesity. http://hum-molgen.org/NewsGen/01-2007/000001.html - Contact Genetic News editors WWW: http://hum-molgen.org/editors.html E-mail: news@hum-molgen.org Biomedical Positions http://hum-molgen.org/positions/ - Computational Genetics / Bioinformatics: Div Vice President of Social & Statistical Sciences Department RTI International, Orange, New Jersey, 07050, United States of America http://hum-molgen.org/positions/non_academic_positions/1692.html - Others: Vice President-Partnership for Genomics and Molecular Epidemiology RTI International, Orange, New Jersey, 07050, United States of America http://hum-molgen.org/positions/non_academic_positions/1694.html - Write a position announcement http://hum-molgen.org/flyer/positions.pdf 1) Set up account: http://hum-molgen.de/cgi-bin/positions.pl?register 2) Post position(s): http://hum-molgen.de/cgi-bin/positions.pl?login Literature http://hum-molgen.org/literature/ Biotechnical requests and sources http://hum-molgen.org/biotechnology - Post request or source http://hum-molgen.org/biotechnical-request-posting Events in bioscience and medicine http://hum-molgen.org/meetings/ - Post event (free) http://hum-molgen.de/cgi-bin/meetings.pl?login Registry of Biomedical Companies (1410 active entries) http://hum-molgen.org/companies/ Mailing List Administration (Join or leave the list) http://hum-molgen.org/subscribe-na/ Feedback contact admin@hum-molgen.org Advertise at HUM-MOLGEN http://hum-molgen.org/flyer/advertise.pdf contact FS Zollmann (dialogue@hum-molgen.org) __________________________________________________________________________ Quantitative PCR March 19-21, 2007 | San Diego, CA http://www.healthtech.com/2007/qpc/index.asp Its simplicity, specificity, and sensitivity, together with the potential for high-throughput and ongoing introduction of new chemistries, more reliable instrumentation, and improved protocols continue qPCR as the validation tool of choice. Learn from savvy, seasoned researchers as they share their experiences with the latest technologies and their cutting edge results at CHI's Quantitative PCR: Replicating and Validating Success. __________________________________________________________________________ -- | INTERNATIONAL COMMUNICATION FORUM IN HUMAN MOLECULAR GENETICS | HUM-MOLGEN - http://hum-molgen.org | (C) 1994-2007